Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

New developments in acute graft-versus-host disease

New developments in acute graft-versus-host disease Allogeneic hematopoietic cell transplantation (HCT) is a well-established curative treatment option for selected patients with hematologic and oncologic diseases. Acute graft-versus-host disease (GvHD) has remained a serious complication of HCT and is associated with high morbidity and mortality especially in patients not responding to first-line therapy with corticosteroids. So far, no standard for salvage therapy of acute corticosteroid-refractory GvHD has been established worldwide. Use of extracorporeal photopheresis results in high response rates, has a steroid-sparing effect and is associated with improved patients’ survival. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

New developments in acute graft-versus-host disease

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/new-developments-in-acute-graft-versus-host-disease-eX2Pq6hIi5
Publisher
Springer Journals
Copyright
Copyright © 2013 by Springer-Verlag Wien
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-013-0080-1
Publisher site
See Article on Publisher Site

Abstract

Allogeneic hematopoietic cell transplantation (HCT) is a well-established curative treatment option for selected patients with hematologic and oncologic diseases. Acute graft-versus-host disease (GvHD) has remained a serious complication of HCT and is associated with high morbidity and mortality especially in patients not responding to first-line therapy with corticosteroids. So far, no standard for salvage therapy of acute corticosteroid-refractory GvHD has been established worldwide. Use of extracorporeal photopheresis results in high response rates, has a steroid-sparing effect and is associated with improved patients’ survival.

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: May 8, 2013

References

  • Graft-versus-host disease
    Ferrara, JL; Levine, JE; Reddy, P; Holler, E
  • The biology of graft-versus-host reactions
    Billingham, RE
  • New perspectives on the biology of acute GVHD
    Paczesny, S; Hanauer, D; Sun, Y
  • National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report
    Filipovich, AH; Weisdorf, D; Pavletic, S
  • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institute of Health consensus criteria
    Flowers, MED; Inamoto, Y; Carpenter, PA
  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation
    Jagasia, M; Arora, M; Flowers, MED
  • Diagnosis and staging of chronic graft-versus-host disease in the clinical practice
    Greinix, HT; Loddenkemper, C; Pavletic, SZ
  • Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health Consensus criteria
    Jagasia, M; Giglia, J; Chinratanalab, W
  • New classification of chronic GVHD: added clarity from the consensus diagnoses
    Arora, M; Nagaraj, S; Witte, J
  • Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
    Couriel, DR; Saliba, R; Escalon, MP
  • Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study
    Kuzmina, Z; Eder, S; Böhm, A
  • Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
    Glucksberg, H; Storb, R; Fefer, A; et, al
  • IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade
    Rowlings, PA; Przepiorka, D; Klein, JP
  • First and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation
    Martin, PJ; Rizzo, JD; Wingard, JR
  • Early treatment of graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation
    Van Lint, MT; Uderzo, C; Locasciulli, A
  • Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
    Mielcarek, M; Storer, BE; Boeckh, M
  • The best endpoint for acute GVHD treatment trials
    MacMillan, M; DeFor, TE; Weisdorf, DJ
  • The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease
    Greinix, HT; Knobler, RM; Worel, N
  • Extracorporeal photochemotherapy for pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation
    Messina, C; Locatelli, F; Lanino, E
  • Assessing the potential role of photopheresis in hematopoietic stem cell transplant
    Greinix, HT; Socie, G; Bacigalupo, A
  • Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease
    Greinix, HT; Worel, N; Knobler, R
  • Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD
    Perfetti, P; Carlier, P; Strada, P
  • Extracorporeal photochemotherapy may improve outcome in children with acute GVHD
    Calore, E; Calo, A; Tridello, G
  • Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients
    Perotti, C; Del Fante, C; Tinelli, C
  • Diagnosis and management of acute graft-versus-host disease
    Dignan, FL; Clark, A; Amrolia, P